Table 2.

Published renal hemodynamic values in T1D, T2D, and nondiabetic controls

	Nondiabetic Controls		T1D
	Younger	Older	Euglycemia	Hyperglycemia	Normofiltration	Hyperfiltration	T2D Overweight
Cohorts
Ref. no.	81	99	81	81	81	81	89
Size, n	25	26	N/A/73	N/A/73	35/73	38/73	52
Cohort characteristics
Age, yr	27 ± 6	50 ± 13	/	/	24 ± 5	23 ± 4	63 ± 7
Female, %	56	50	/	/	40	55	25
Renal hemodynamic parameters
GFR	117 ± 11	95 ± 24	144 ± 32.9	156 ± 30.7	116 ± 10	177 ± 35	82 ± 4
ERPF, ml·min−1·1.73 m−2	628 ± 162	497 ± 172	810 ± 269	831 ± 236	642 ± 93	970 ± 268	345 ± 18
RBF, ml·min−1·1.73 m−2	1,039 ± 287	810 ± 279	1,299 ± 439	1,309 ± 399	1,031 ± 171	1,552 ± 466	605 ± 32
RVR, mmHg/min	0.081 ± 0.019		0.068 ± 0.02	0.067 ± 0.017	0.080 ± 0.014	0.057 ± 0.017	0.184 ± 0.012
FF	0.19 ± 0.04	0.20 ± 0.06	0.18 ± 0.04	0.19 ± 0.05	0.18 ± 0.03	0.18 ± 0.06	0.24 ± 0.01
Filtration pressure, mmHg	22.4 ± 2.2		28 ± 6	30 ± 7	22 ± 2	32 ± 5
RA, dyn·s−1·cm−5	1,676 ± 706	3,778 ± 2856	1,473 ± 798	1,325 ± 825	2,065 ± 597	914 ± 494	6,176 ± 607
RE, dyn·s−1·cm−5	2,043 ± 463	1,596 ± 1,195	2,021 ± 590	2,205 ± 716	1,993 ± 367	2,047 ± 747	3,957 ± 105
PGLO, mmHg	60 ± 3	52 ± 8	61 ± 8	62 ± 8	55 ± 3	66 ± 6	60 ± 1
Oncotic pressure, mmHg	27 ± 3		23 ± 3	22 ± 3	22 ± 3	24 ± 3

Data are means ± SD; n, no. of subjects. ERPF, effective renal plasma flow; RVR, renal vascular resistance.